文献速递妇科

教科书式结局作为复合结局指标比较卵巢癌肿瘤细胞减灭术的医院表现:一项全国性人群研究

Textbook outcome as a composite outcome measure to compare hospital performances regarding cytoreductive surgery for ovarian cancer: A nationwide population-based study.
PubMed 文献 · Gynecol Oncol · 2023-05-09

这项基于荷兰2017至2020年登记数据的全国性人群研究纳入1909例FIGO IIIC-IVB期原发性卵巢癌肿瘤细胞减灭术,构建教科书式结局(TO)作为复合质量指标,定义为完全减灭且无30天死亡、严重并发症和住院时间延长(≥10天)。间隔减灭术组TO率54%,初次减灭术组47%;术后肉眼残留病灶是未达TO的最重要因素,年龄≥70与较低TO率相关,医院间TO率差异明显,病例组合校正可提高医院比较准确性。

要点

  • TO定义为完全减灭且无30天死亡、严重并发症和住院≥10天。
  • 间隔减灭术组TO率54%,初次减灭术组TO率47%。
  • 术后肉眼残留病灶是未达TO的最重要因素。

核心结论

  • TO是检测晚期卵巢癌肿瘤细胞减灭术医疗质量医院间差异的合适复合结局指标。
  • 病例组合校正可提高医院比较的准确性。

研究设计与样本

  • 基于荷兰2017至2020年登记数据的全国性人群研究,纳入所有FIGO IIIC-IVB期原发性卵巢癌肿瘤细胞减灭术。
  • 共纳入1909例肿瘤细胞减灭术,其中间隔减灭术1434例,初次减灭术475例。
  • TO定义为完全减灭且无30天死亡、无严重并发症、无住院时间延长(≥10天)。
  • 因数据缺失,辅助化疗延迟启动(≥6周)未纳入TO。
  • 采用逻辑回归评估病例组合因素与TO的关联,用漏斗图展示医院间差异。

主要发现

  • 间隔减灭术队列TO率为54%,初次减灭术队列TO率为47%。
  • 术后肉眼残留病灶是未达TO的最重要因素。
  • 多变量逻辑回归中,年龄≥70岁与较低TO率相关。
  • 间隔减灭术队列医院间TO率范围为40%至69%,初次减灭术队列为22%至100%。
  • 两项分析中各有1家医院TO率显著较低(为不同医院);病例组合校正显著影响初次减灭术分析的TO率。

关键数值与推荐

  • TO定义:完全减灭且无30天死亡、无严重并发症、住院时间<10天。
  • 辅助化疗延迟启动(≥6周)因数据缺失未纳入TO。
  • 间隔减灭术队列TO率54%,初次减灭术队列TO率47%。
  • 间隔减灭术队列医院间TO率40%至69%,初次减灭术队列22%至100%。

局限性

  • 辅助化疗延迟启动(≥6周)因数据缺失未纳入TO。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Textbook outcome (TO) is a composite outcome measure used in surgical oncology to compare hospital outcomes using multiple quality indicators. This study aimed to develop TO as an outcome measure to assess healthcare quality for patients undergoing cytoreductive surgery (CRS) for advanced-stage ovarian cancer. METHODS: This population-based study included all CRS for FIGO IIIC-IVB primary ovarian cancer registered in the Netherlands between 2017 and 2020. The primary outcome was TO, defined as a complete CRS, combined with the absence of 30-day mortality, severe complications, and prolonged length of admission (≥ten days). Delayed start of adjuvant chemotherapy (≥six weeks) was not included in TO because of missing data. Logistic regressions were used to assess the association of case-mix factors with TO. Hospital variation was displayed using funnel plots. RESULTS: A total of 1909 CRS were included, of which 1434 were interval CRS and 475 were primary CRS. TO was achieved in 54% of the interval CRS cohort and 47% of the primary CRS cohort. Macroscopic residual disease after CRS was the most important factor for not achieving TO. Age ≥ 70 was associated with lower TO rates in multivariable logistic regressions. TO rates ranged from 40% to 69% between hospitals in the interval CRS cohort and 22% to 100% in the primary CRS cohort. In both analyses, one hospital had significantly lower TO rates (different hospitals). Case-mix adjustment significantly affected TO rates in the primary CRS analysis. CONCLUSIONS: TO is a suitable composite outcome measure to detect hospital variation in healthcare quality for patients with advanced-stage ovarian cancer undergoing CRS. Case-mix adjustment improves the accuracy of the hospital comparison.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Algera MD, Slangen BFM, van Driel WJ, et al. Textbook outcome as a composite outcome measure to compare hospital performances regarding cytoreductive surgery for ovarian cancer: A nationwide population-based study. Gynecol Oncol. 2023. PMID: 37167897. doi:10.1016/j.ygyno.2023.04.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。